Sarepta Therapeutics, Inc. financial data

Symbol
SRPT on Nasdaq
Industry
Pharmaceutical Preparations
Location
215 First Street, Suite 415, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
AVI BIOPHARMA INC (to 7/12/2012), ANTIVIRALS INC (to 5/12/1998)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 424 % -5.66%
Quick Ratio 59.4 % +56.9%
Debt-to-equity 256 % -43.1%
Return On Equity 5.17 %
Return On Assets 1.45 %
Operating Margin 2.52 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95.4M shares +2.24%
Common Stock, Shares, Outstanding 95.3M shares +2.15%
Common Stock, Value, Issued 10K USD +11.1%
Weighted Average Number of Shares Outstanding, Basic 94.6M shares +6.62%
Weighted Average Number of Shares Outstanding, Diluted 99.1M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.5B USD +50%
Revenue from Contract with Customer, Excluding Assessed Tax 1.39B USD +52.5%
Costs and Expenses 1.47B USD -3.06%
Operating Income (Loss) 38M USD +99.5%
Nonoperating Income (Expense) 24.2M USD -88%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 62.2M USD
Income Tax Expense (Benefit) 14.9M USD -34.1%
Net Income (Loss) Attributable to Parent 47.3M USD
Earnings Per Share, Basic 0.78 USD/shares
Earnings Per Share, Diluted 0.77 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 384M USD -55%
Cash, Cash Equivalents, and Short-term Investments 1.69B USD -15.8%
Accounts Receivable, after Allowance for Credit Loss, Current 360M USD +52%
Inventory, Net 486M USD +114%
Other Assets, Current 74.7M USD -49.6%
Assets, Current 2.68B USD +8.53%
Property, Plant and Equipment, Net 276M USD +46.2%
Operating Lease, Right-of-Use Asset 124M USD -7.96%
Other Assets, Noncurrent 136M USD -16.8%
Assets 3.42B USD +9.55%
Accounts Payable, Current 107M USD -2.17%
Employee-related Liabilities, Current 50M USD +11.4%
Accrued Liabilities, Current 350M USD +7.2%
Contract with Customer, Liability, Current 122M USD +171%
Liabilities, Current 688M USD +38.1%
Contract with Customer, Liability, Noncurrent 325M USD -33%
Operating Lease, Liability, Noncurrent 144M USD +11.2%
Other Liabilities, Noncurrent 7.09M USD +18550%
Liabilities 2.35B USD -1.56%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.03M USD +2.37%
Retained Earnings (Accumulated Deficit) -4.4B USD +1.06%
Stockholders' Equity Attributable to Parent 1.08B USD +45.3%
Liabilities and Equity 3.42B USD +9.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -242M USD -15.6%
Net Cash Provided by (Used in) Financing Activities 22.1M USD -78.3%
Net Cash Provided by (Used in) Investing Activities 219M USD +1651%
Common Stock, Shares Authorized 198M shares 0%
Common Stock, Shares, Issued 95.3M shares +2.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.14M USD +98.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 399M USD -54.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.19M USD +2.35%
Deferred Tax Assets, Valuation Allowance 884M USD +8.84%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 912M USD +10.8%
Operating Lease, Liability 159M USD +117%
Payments to Acquire Property, Plant, and Equipment 32.4M USD +242%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 47.3M USD
Lessee, Operating Lease, Liability, to be Paid 399M USD +292%
Property, Plant and Equipment, Gross 418M USD +27.1%
Operating Lease, Liability, Current 17.8M USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 34.5M USD +66.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 33.7M USD +60.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 240M USD +738%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28M USD +82.8%
Deferred Tax Assets, Operating Loss Carryforwards 155M USD -35.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3.33M shares 0%
Unrecognized Tax Benefits 65M USD +5.39%
Lessee, Operating Lease, Liability, to be Paid, Year Four 28M USD +232%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 10.5M USD
Current Federal Tax Expense (Benefit) 2.9M USD
Amortization of Intangible Assets 2.4M USD +237%
Depreciation, Depletion and Amortization 8.74M USD -22.7%
Share-based Payment Arrangement, Expense 185M USD -2.43%
Interest Expense 19.5M USD -41%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%